Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
Classification, diagnosis, screening and prevention (Update 2019)
The project was launched at the end of 2018, and all five global registration trials have been completed
9 of 95 products 9 of 9 products shown cagrilintide From$58.99 CAS 1415456-99-3 MW 4409.07 cagrilintide from the Nexus GLP-1 & Metabolic catalog, supplied for controlled in-vitro research workflows
Peripheral artery disease (PAD) is a prevalent and debilitating manifestation of systemic atherosclerosis that disproportionately affects individuals with type 2 diabetes (T2D)
US$ 21.03
US$ 24.44
US$ 24.29
US$ 28.44
US$ 20.40
US$ 24.48
US$ 29.14
